Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Objective: To review the current status of radiofrequency ablation (RFA) in the management
of hepatocellular carcinoma (HCC). Summary Background Data: The development of local …

Background & Aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first-line therapeutic option. However, such a strategy is still …

Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …

Background Despite being one of the commonest causes of cancer-related death around
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …

Purpose To compare prospectively the effects of radiofrequency (RF) ablation after
transcatheter arterial chemoembolization (TACE) with those of RF ablation alone in the …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Abstract Background and Aim To determine and compare the adverse events and long‐term
effectiveness for patients with small hepatocellular carcinoma (HCC)(≤ 3 cm) treated by …

PURPOSE: To examine the safety and efficacy of Cyberknife stereotactic body radiation
therapy (SBRT) and its effect on survival in patients of recurrent hepatocellular carcinoma …